-
Electronic (PDF)
-
Site License
-
Enterprisewide
NRT Smoking Cessation Aids in France
Euromonitor International, April 2012, Pages: 34
According to trade press, the number of smokers that tried to stop or to reduce their consumption of tobacco increased again between 2010 and 2011. This context was favourable to NRT smoking cessation aids, as in order to stop or reduce smoking, smokers did not hesitate to self-medicate.
Euromonitor International's NRT Smoking Cessation Aids in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
NRT SMOKING CESSATION AIDS IN FRANCE
Euromonitor International
April 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2006-2011
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
Table 4 NRT Gum Flavours: % Value Breakdown 2006-2011
Table 5 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
Table 6 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016
Laboratoires Mcneil in Consumer Health (france)
Strategic Direction
Key Facts
Summary 1 Laboratoires McNeil: Key Facts
Summary 2 Laboratoires McNeil: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Laboratoires McNeil: Competitive Position 2011
Pierre Fabre Sa, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
Summary 4 Laboratoires Pierre Fabre SA: Key Facts
Summary 5 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
Summary 6 Laboratoires Pierre Fabre SA: Production Statistics 2011
Competitive Positioning
Summary 7 Laboratoires Pierre Fabre SA: Competitive Position 2011
Executive Summary
Consumer Health Registers Low But Positive Value Growth in 2011
Ageing Population and Concentration in Urban Areas, Key Growth Drivers
Direct Selling and Herbal Products Behind Best-performing Operators
Pharmacies Still the Most Common Retailer for Consumer Health Products
Modest Growth Expected Over the Forecast Period
Key Trends and Developments
Hectic Lifestyles Behind Good Performances of Some Categories of OTC Drugs
Ageing Population A Major Driver for Consumer Health
Weight Management, the Most Affected by the Weak Economic Context
Transfer of Rx Drugs To OTC Market Continues To Boost Growth Potential
French Consumers Increasingly Receptive To Oral Nrt Smoking Cessation Aids
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
Summary 8 OTC - Switches 2009-2011
Definitions
Sources
Summary 9 Research Sources
Less mature sectors remain dynamic
Sales of vitamins and dietary supplements, antihistamines and emergency contraception, amongst others, remained strong. This highlights the fact that the impetus for growth in OTC healthcare is from products associated with a healthy lifestyle or those needed in case of emergency (such as antihistamines and emergency contraception). NRT smoking cessation aids, nevertheless, saw a reversal of fortunes due to a lack of promotional effort to sustain sales.
Companies Mentioned Include:
- UPSA, Laboratoires
- Théraplix SA
- Pierre Fabre SA, Laboratoires
- Urgo, Laboratoires
- Sanofi-Synthélabo France SA
- Pfizer Santé Grand Public
- Beaufour-Ipsen SA
- Arkopharma SA
- Laboratoires Martin-Johnson & Johnson-MSD SAS
- GlaxoSmithKline Santé Grand Public SAS
- Ricola AG
- Bayer Santé Familiale
- Juva Santé, Laboratoires
- Laboratoires Roche Nicholas SAS
- Boots Healthcare International Ltd
- Whitehall Laboratories Ltd
- Laboratoires du Docteur E Bouchara
- Janssen Cilag
- Lachartre, Laboratoire
- Novartis Group France SA
- Pharmacia SNC
- Beiersdorf SA
- Boehringer Ingelheim France SAS
- Laboratoires Mercurochrome
- Viatris GmbH & Co KG
- Gifrer Barbezat SA
- Solvay Pharma
- Orgamol SA
- Laboratoire Oenobiol
- Cadbury France SA
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
